New drugs for the management of tuberculosis. [PDF]
Cross GB.
europepmc +1 more source
Recent advances in tuberculosis treatment: Towards shorter, safer, and more effective therapies. [PDF]
Timboe K, Jackson JB, Becker GL.
europepmc +1 more source
Pipeline of anti-Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities. [PDF]
Egorova A +3 more
europepmc +1 more source
A strategy to re-sensitise drug-resistant Gram-positive bacteria to oxazolidinone-class antibiotics. [PDF]
Zhang Q +11 more
europepmc +1 more source
Neuromyelitis optica causing vision loss during TB treatment with sutezolid: evidence of aberrant immunity following infection. [PDF]
Glover NA +13 more
europepmc +1 more source
Tuberculosis parenteral therapeutic regimens for critical patients or non-functional intestinal tract: Brief review and proposal of protocol. [PDF]
Martins AC, Garcia MT, Resende MR.
europepmc +1 more source
Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment. [PDF]
Stephanie F, Saragih M, Tambunan USF.
europepmc +1 more source
Drug-Resistant Tuberculous Meningitis (DR-TBM) in a Low-Incidence Setting: Two Cases and an Evidence Review Highlighting Key Advances and Knowledge Gaps in Clinical Management. [PDF]
Boschung KF +7 more
europepmc +1 more source
Durable three-year outcomes and persistent neuropathy following nine-month all-oral regimens for rifampicin-resistant tuberculosis: a multicentre cohort study in China. [PDF]
Fu L +13 more
europepmc +1 more source

